EI
CNCE
EAM Investors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-884,969
| Closed | -$5.93M | – | 372 |
|
|
2022
Q3 | $5.93M | Buy |
884,969
+34,322
| +4% | +$230K | 1.29% | 1 |
|
|
2022
Q2 | $3.58M | Buy |
+850,647
| New | +$3.58M | 0.87% | 8 |
|
|
2018
Q1 | – | Sell |
-34,905
| Closed | -$903K | – | 384 |
|
|
2017
Q4 | $903K | Buy |
+34,905
| New | +$903K | 0.16% | 217 |
|
|
2016
Q2 | – | Sell |
-120,423
| Closed | -$1.65M | – | 391 |
|
|
2016
Q1 | $1.65M | Sell |
120,423
-12,894
| -10% | -$176K | 0.26% | 178 |
|
|
2015
Q4 | $2.53M | Sell |
133,317
-804
| -0.6% | -$15.3K | 0.33% | 145 |
|
|
2015
Q3 | $2.52M | Buy |
134,121
+51,802
| +63% | +$972K | 0.4% | 100 |
|
|
2015
Q2 | $1.23M | Sell |
82,319
-115
| -0.1% | -$1.71K | 0.14% | 269 |
|
|
2015
Q1 | $1.25M | Buy |
+82,434
| New | +$1.25M | 0.14% | 273 |
|
|
2014
Q4 | – | Sell |
-303,142
| Closed | -$3.82M | – | 379 |
|
|
2014
Q3 | $3.82M | Buy |
+303,142
| New | +$3.82M | 0.78% | 5 |
|